This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Antibody Engineering & Therapeutics US
December 15 - 18, 2024
Marriott Marquis San DiegoLive In-Person Event: December 15 - 18, 2024

Dr. Angus Sinclair, PhD
Executive Vice President, Research at IGM Biosciences
Speaker

Profile

Dr. Sinclair joined us in 2018 and is our Executive Vice President of Research. Prior to joining IGM, Dr. Sinclair served as Senior Director, Oncology Research at Northern Biologics, a biotechnology company, from 2015 to 2018. He also previously served in various scientific and leadership positions at Amgen, including most recently as Scientific Director, Oncology Research, from 2011 to 2015. Dr. Sinclair received a B.Sc. in Molecular Biology from the University of Edinburgh and a Ph.D. in Hematology/Molecular Biology from the National Institute for Medical Research/University College London.

Agenda Sessions

  • Co-stimulatory IgM T-cell Engagers with Enhanced and Durable Cytotoxicity against Solid Tumors

    4:45pm